Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Alexion Pharmaceuticals a Buy?

TheMotleyFool

0 0

Is Alexion Pharmaceuticals a Buy?Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

There are plenty of promising biotech stocks for investors to sift through right now. One of these companies is Alexion Pharmaceuticals (NASDAQ: ALXN), a developer of treatments for rare diseases that has seen tremendous success with its flagship drug, Soliris.

With management expecting further sales growth, there's a lot of potential upside for this company in the future. At the same time, its shares are trading quite cheaply in comparison to other biotech companies'.

Does that make this stock an automatic buy in 2020? Let's find out.

Source Fool.com

Like: 0

ALXN

Share